Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agarose for a bioartificial pancreas.

H Iwata1, T Takagi, H Amemiya

  • 1National Cardiovascular Center Research Institute, Osaka, Japan.

Journal of Biomedical Materials Research
|July 1, 1992
PubMed
Summary

Agarose microbeads effectively encapsulate islets, prolonging allograft survival in diabetic mouse models. This approach shows promise for bioartificial pancreas development without immunosuppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement as a risk factor for late recurrence (>1 year) of hepatocellular carcinoma after surgery.

Clinical radiology·2019
Same author

Cellular responses of rat periodontal ligament cells under hypoxia and re-oxygenation conditions in vitro.

Journal of periodontal research·2007
Same author

Characterization of new monoclonal antibodies against porcine lymphocytes: molecular characterization of clone 7G3, an antibody reactive with the constant region of the T-cell receptor delta-chains.

Veterinary immunology and immunopathology·2005
Same author

Early infant kidneys as marginal donor sources: histology and pathophysiology.

Transplantation proceedings·2002
Same author

Overexpression of redox factor-1 protects against postischemic liver injury by reducing oxidative stress and NF-kappa B activity.

Transplantation proceedings·2002
Same author

Establishment of public human tissue resource bank for research purposes with surgically removed tonsil tissue: potential scientific value and ethical problem.

Transplantation proceedings·2002

Area of Science:

  • Biomaterials Science
  • Immunology
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of pancreatic beta cells.
  • Islet transplantation is a potential T1D treatment but faces challenges with graft survival and the need for immunosuppression.
  • Microencapsulation offers a strategy to protect transplanted islets from immune rejection.

Purpose of the Study:

  • To evaluate the efficacy of agarose microbead microencapsulation in extending islet allograft survival.
  • To assess the function of microencapsulated islets in streptozotocin-induced diabetic (STZ) and nonobese diabetic (NOD) mouse models.
  • To determine if microencapsulation can obviate the need for immunosuppressive drugs.

Main Methods:

  • Islets were encapsulated in 5% agarose microbeads.

Related Experiment Videos

  • Microencapsulated islets were transplanted into STZ-induced diabetic BALB/c mice and NOD mice.
  • Graft survival and glycemic control (normoglycemia) were monitored post-transplantation.

    • Main Results:

    • All STZ-diabetic mice receiving microencapsulated islets maintained normoglycemia indefinitely.
    • In NOD mice, 4 out of 5 microencapsulated islet grafts functioned for over 80 days.
    • Two NOD mice maintained normoglycemia for 102 and 192 days, respectively, without immunosuppression.

    Conclusions:

    • Commercially available agarose microbeads effectively prolong alloislet function in both STZ and NOD mouse models.
    • Microencapsulation of islets in agarose beads is a promising strategy for creating a functional bioartificial pancreas.
    • This approach can potentially eliminate the requirement for immunosuppressive therapy in islet transplantation for T1D.